Tudóstér: Kissné Bogáti Réka publikációi

Kállai, J., Gindele, R., Pénzes-Daku, K., Balogh, G., Kissné Bogáti, R., Bécsi, B., Katona, É., Oláh, Z., Ilonczai, P., Boda, Z., Róna-Tas, Á., Nemes, L., Marton, I., Bereczky, Z.: Clinical and Molecular Characterization of Nine Novel Antithrombin Mutations.
Int. J. Mol. Sci. 25 (5), 1-19, 2024.

Pituk, D., Balogh, L., Horváth, E., Hegyi, Z., Baráth, B., Kissné Bogáti, R., Szűcs, P., Papp, Z., Katona, É., Bereczky, Z.: Localization of Hemostasis Elements in Aspirated Coronary Thrombi at Different Stages of Evolution.
Int. J. Mol. Sci. 25 (21), 1-19, 2024.

Kissné Bogáti, R., Katona, É., Shemirani, A., Balogh, E., Bárdos, H., Jeney, V., Muszbek, L.: The Effect of Activated FXIII, a Transglutaminase, on Vascular Smooth Muscle Cells.
Int. J. Mol. Sci. 23 (10), 1-15, 2022.

Baráth, B., Kissné Bogáti, R., Miklós, T., Kállai, J., Mezei, Z., Bereczky, Z., Muszbek, L., Katona, É.: Effect of [alfa]2-plasmin inhibitor heterogeneity on the risk of venous thromboembolism.
Thromb. Res. 203 110-116, 2021.

Bagoly, Z., Baráth, B., Orbán-Kálmándi, R., Szegedi, I., Kissné Bogáti, R., Sarkady, F., Csiba, L., Katona, É.: Incorporation of [alfa]2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients.
Biomolecules. 11 (3), 1-13, 2021.

Gindele, R., Pénzes-Daku, K., Balogh, G., Kállai, J., Kissné Bogáti, R., Bécsi, B., Erdődi, F., Katona, É., Bereczky, Z.: Investigation of the Differences in Antithrombin to Heparin Binding among Antithrombin Budapest 3, Basel, and Padua Mutations by Biochemical and In Silico Methods.
Biomolecules. 11 (4), 1-18, 2021.

Katona, É., Kissné Bogáti, R., Miklós, T., Gindele, R., Speker, M., Fedoriska, V., Orosz, A., Mezei, Z., Bereczky, Z.: ALPHA-2 Plasmin Inhibitor Activity and Antigen Levels and p.Arg6Trp Polymorphism in Patients with Venous Thromboembolism.
Proceedings. 2 (9), 102-103, 2018.

Katona, É., Kissné Bogáti, R., Miklós, T., Gindele, R., Speker, M., Fedoriska, V., Orosz, A., Mezei, Z., Bereczky, Z.: The Effect of Alpha-2 Plasmin Inhibitor Activity and Antigen Levels and p.Arg6Trp Polymorphism on the Risk of Venous Thromboembolism.
Res Pract Thromb Haemost. 2 324-324, 2018.

Korponay-Szabó, I., Kerekes-Tóth, B., Gyimesi, J., Bartáné Tóth, B., Kissné Bogáti, R., Király, R., Caja, S., Nadalutti, C., Lindfors, K., Mäki, M., Fésüs, L.: Search for gluten non-dependent prospective biomarkers for in vitro diagnostic use: 16th International Coeliac Disease Symposium 21-24 June 2015, Prague.

Tóth, B., Kissné Bogáti, R., Király, R., Simon-Vecsei, Z., Caja, S., Bartáné Tóth, B., Nadalutti, C., Lindfors, K., Mäki, M., Fésüs, L., Korponay-Szabó, I.: Lipoma-preferred partner protein (LPP), a genetic marker for coeliac disease predisposition is interacting with transglutaminase 2.
JPGN. 56 (Suppl_2), 200, 2013.

Tóth, B., Kissné Bogáti, R., Király, R., Simon-Vecsei, Z., Caja, S., Bartáné Tóth, B., Nadalutti, C., Lindfors, K., Mäki, M., Fésüs, L., Korponay-Szabó, I.: Lipoma-preferred partner protein (LPP), a genetic marker for coeliac disease predisposition is interacting with transglutaminase 2: 46th Annual Meeting of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN).